Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
Related Research units
Bibliographical data
Original language | English |
---|---|
ISSN | 1365-7852 |
DOIs | |
Publication status | Published - 12.2023 |
PubMed | 36899091 |
---|